ESCRS 2023: Thomas Bosshard discusses Oertli's 3-platform approach

News
Video

At this year's ESCRS meeting, we visited the Oertli Instruments booth, where co-CEO and co-owner Thomas Bosshard highlighted the company's 3-platform approach.

At this year's European Society of Cataract and Refractive Surgeons (ESCRS) meeting in Vienna, Austria, we visited the Oertli Instruments booth, where co-CEO and co-owner Thomas Bosshard highlighted the company's 3-platform approach. Here's our conversation, live from the congress floor.

Editor's note: This transcript has been edited for clarity.

Thomas Bosshard: Hey guys my name is Thomas, Thomas Bosshard. I'm the co-owner and CO-CEO of Oertli Instruments in Switzerland. We are proud to bring to the ESCRS, of course, our 3-platform strategy with the OS4, the CataRhex 3 and the Faros, which are highly renowned for super dynamic cataract surgery and vitrectomy surgery. With all its features, peripheral products and of course, along with it, our highly dynamic team, which is here for our customers and partners.

Probably the most interesting thing which we are currently featuring and getting more and more wild and exciting about is our Speed Mode with our with our CataRhex 3 and all our other platforms, which is a highly effective tool for safer and simpler surgery, whether it's in cataract or vitrectomy procedures.

In 2024, you should be excited about quite great pipeline which we are about to start early over the next few years which is to come. It's going to be a very interesting time from 2024 on, at and around Oertli Instruments.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.